NEOGENOMICS INC — Director's Dealing 2020

Jun 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-05-28

Reporting Person: JONES STEVEN C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-28	Common Stock	A	2698	—	Acquired	197932	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-28	Stock Options (Right to Buy)	$28.54	A	3448	Acquired	2027-05-28	Common Stock (3448.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1500000	Indirect
Common Stock	40757	Indirect
Common Stock	125000	Indirect
Common Stock	30476	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (100000.0)	100000	Indirect
Stock Option (Right to Buy)	$7.27	2022-05-25	Common Stock (10000.0)	10000	Direct
Stock Option (Right to Buy)	$11.6	2023-06-01	Common Stock (3017.0)	3017	Direct
Stock Option (Right to Buy)	$22.52	2026-06-06	Common Stock (4269.0)	4269	Direct

Footnotes

F1: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F2: On April 20, 2016, Mr. Jones was granted 100,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F3: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vest ratably on the first three anniversary dates of the grant date.